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Background: Stress is a limiting factor in assisted reproduction in wild animals maintained in captivity. However,
the knowledge of assisted reproduction techniques for wild animals is useful for future in situ and ex situ
conservation programs. Thus, this study evaluated the ovulation rate, presence of functional corpora lutea and fecal
glucocorticoid levels following treatments promoting superovulation in captive brown brocket deer.
Methods: The crossover design used six hinds, allocated to two groups (n = 6): eCG Treatment, CIDR for 8 days,
followed by 0.25 mg of EB on day 0, 700 IU of eCG on day 4 following device insertion and 265 mug of PGF2alfa
on day 8; and FSH Treatment, CIDR for 7.5 days, followed by 0.25 mg of EB on day 0, 130 mg of FSH in 8 equal
doses and 265 mug of PGF2alfa on day 7.5. Induced adrenal activity and treatment efficacy were evaluated by
corpora lutea (CL) counts and fecal glucocorticoid and progestin concentration (ng/g feces) analyses for five
different phases: Pre, two days before treatment; Early, first four days of treatment; Late, last four days of treatment;
Total, entire treatment period; and Post, five days posttreatment.
Results: eCG Treatment resulted in the highest number of CL (P lower than 0.05). There was no significant difference
for fecal glucocorticoid concentrations in five different time periods between the treatments; however Pre fecal
glucocorticoid concentrations (90.06+/−19.64) were significantly different from Late (200.76+/−26.39) within
FSH Treatment. The mean fecal progestin concentration and mean ovulation rate were higher in eCG Treatment
(4293.69+/−769.47, 7.0+/−1.8) than in FSH Treatment (1571.26+/−240.28, 2.6+/−0.8) (P lower than or equal to 0.05).
Conclusions: Although the eCG Treatment induced a good superovulatory response, with the formation of functional
corpora lutea, we cannot yet affirm that we have established a suitable protocol for induction of SOV in the species
M. gouazoubira because approximately 65% of the deer showed premature regression of the corpora lutea. Moreover,
multiple FSH applications in FSH Treatment resulted in a low ovulation rate and induced an increase in fecal
glucocorticoid levels.
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The brown brocket deer (Mazama gouazoubira) is one of
the most abundant species in the Neotropical region [1]
and is classified as LC (least concern) in the IUCN Red
List [2]. It is considered a monovulatory nonseasonal
breeder, giving birth throughout the year [3,4]. Data from* Correspondence: eveline_zanetti@yahoo.com.br
Deer Research and Conservation Center (NUPECCE, Núcleo de Pesquisa e
Conservação de Cervídeos), Departamento de Zootecnia, Faculdade de
Ciências Agrárias e Veterinárias, Universidade Estadual Paulista, Via de Acesso
Professor Paulo Donato Castellane s/n, Jaboticabal, SP zip code:
14884-900, Brazil
© 2014 Zanetti et al.; licensee BioMed Central
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.endocrinology studies, based on progestogen data, indicate
a mean luteal phase duration of 24.6 ± 1.4 day and a mean
interluteal phase duration of 1.7 ± 0.1 day [3]. It is also
one of the most studied species regarding the endocrin-
ology of the estrous cycle and pregnancy [3] and the devel-
opment of reproductive biotechnologies, such as estrus
synchronization [5,6] and superovulation [5,7].
The abundance of this species and the preceding studies,
which increased knowledge concerning the species, favor
its use as an experimental model to evaluate reproductive
techniques that could be used as a starting point for otherLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
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classified as vulnerable or threatened with extinction [2].
Among the available biotechnologies, stimulation of
follicular growth to induce superovulation is essential to
the success and efficiency of embryo transfer and in vitro
fertilization programs [8], techniques that permit complete
flexibility in sire/dam pairings [9]. Although multiple ovu-
lation has been performed successfully in brown brocket
[7], red (Cervus elaphus [8-17], fallow (Dama dama
[11,13,18]), Pere David’s (Elaphurus davidianus [15]),
white-tailed deer (Odocoileus virginianus, [19]), and some
other domestic species [20,21], the procedure often results
in highly variable superovulatory responses [10,20,21] and
thus it is the weakest link in the chain of events required
for successful multiple ovulation/embryo transfer technol-
ogy (MOET) [22].
The wide variation in the superovulatory response could
be related to numerous factors, such as the status of fol-
licular development of the deer at the time superovulatory
treatment was initiated [20], age, weight, nutrition, season,
the type and combination of gonadotropins used and gen-
etic factors [23]. Moreover, the stress induced by intense
manipulation of the deer during assisted reproductive pro-
cedures is a particularly important factor in wild animals
and could explain the poor responses obtained in wild un-
gulates [24]. Multiple ovulation protocols involve a single
injection of equine chorionic gonadotropin (eCG) and/or
multiple injections of follicle stimulating hormone (FSH)
[13] and should be designed to eliminate as much hand-
ling stress as possible [25].
Several studies of domestic and wild animals have
discussed the influence of stress on reproductive func-
tion in females [24,26-28] and one widely used method
to determine this in mammals is the evaluation of ad-
renal gland activity in the production of catecholamine
and glucocorticoids, particularly the latter, which are
commonly used as indicators of biological neuroendo-
crine response to stress [29]. For this reason, many re-
searchers and conservationists have begun to use a
noninvasive method, involving indirect measurement
of glucocorticoid metabolites as a means to determine
stress in several animal species [30], since blood collec-
tion for plasma glucocorticoid quantification is known
to cause stress, especially in wild animals, disturbing
the final outcomes of the analysis [31].
The quantification of fecal glucocorticoids has been
used to evaluate the influence of husbandry systems on
the physiological stress of captive brown brocket deer
[32]; however, to the best of our knowledge, no informa-
tion is available concerning the consequences of stress
on superovulation protocols in this species or in other
neotropical cervids. Thus, the aim of this study was to
evaluate the ovulation rate, the presence of functional
corpora lutea and fecal glucocorticoid levels followingtwo distinct treatments designed to promote superovu-
lation in captive brown brocket deer.
Methods
This study was approved by the Animal Ethics and
Welfare Committee (Comitê de Ética e Bem-estar Animal,
CEBEA) of the Faculty of Agrarian and Veterinary Sci-
ences (Faculdade de Ciências Agrárias e Veterinárias,
FCAV) UNESP, Jaboticabal, SP, Brazil (protocol number
013147–06, 02-08-2006).
Animals
Six adult hinds (primiparous, aged 2.0 to 4.0 years-old,
weighing 12.9 to 20.6 kg) and 1 male (vasectomized,
3.0 years-old, weighing 18.0 kg) were housed at the Deer
Research and Conservation Center (NUPECCE) facilities
at the São Paulo State University (UNESP), Jaboticabal
Campus (20°S latitude). From March through August
2009, all the deer were maintained individually in stalls
(3 m × 2 m) with auditory and olfactory contact with con-
specific males and females and were exposed to normal
fluctuations in the photoperiod. They were fed ad libitum
with a diet consisting of a pelleted ration (12% crude pro-
tein, 2% crude fat, 10% crude fiber, Purina Co.; Paulínia,
São Paulo, Brazil) and approximately 1 kg/deer/day of
fresh alfalfa (Medicago sativa), perennial soybean (Neono-
tonia wightii) or mulberry branches (Morus alba). Water
was also provided ad libitum.
Estrus synchronization and superovulation treatment
Initially, on a random day of the estrous cycle, the hinds
were divided into two groups (n = 6): (i) eCG Treatment,
in which the hinds received a single intravaginal device
containing 0.33 g of progesterone (CIDR-type T; Con-
trolled Internal Drug Release; Pfizer, USA) for eight days
[6], followed by 0.25 mg i.m. injection of estradiol benzoate
(EB) (0.25 mL Estrogin; Farmavet Produtos Veterinários
Ltda, Brazil) [33,34] on the same day as the device was
inserted (to induce atresia in ovarian follicles) [20], 700UI i.
m. injection of eCG (3.5 mL Folligon 1000; Intervet Inter-
national BV; Holland) on day 4 following device insertion
(to induce superovulation, SOV) and 265 μg i.m. injection
of PGF2α (265 μg cloprostenol; 1 mL Ciosin; Schering
Plough Coopers, Brazil) on the day the device was removed,
to ensure that any persistent luteal tissue was removed
upon progesterone withdrawal [6]; (ii) FSH Treatment, in
which the hinds received a single intravaginal device con-
taining 0.33 g of progesterone for 7.5 days, followed by
0.25 mg i.m. injection of EB on the same day as the device
was inserted, 130 mg i.m. of FSH (6.5 mL Folltropin-V;
Bioniche Animal Health; Canada) applied in 8 equal
doses, such that the first dose was administered on day
4.5 post-insertion of the device and the last dose was
administered 12 h following its removal, and 265 μg i.m.
Zanetti et al. Reproductive Biology and Endocrinology 2014, 12:24 Page 3 of 9
http://www.rbej.com/content/12/1/24injection of PGF2α on the day the device was removed
(Figure 1). Each hind received the treatments in a cross-
over design; all the deer were submitted to both treat-
ments [35]. The interval between the treatments was
44–48 days following the end (removal of the intravagi-
nal device, CIDRW) of the first treatment which the hind
was submitted. This experimental design was adopted
in an attempt to control temporal effects, to reduce the
effect of one treatment on the other, to control hind
variability, while evaluating treatment effects, and be-
cause of the limited number of experimental animals
available and the difficulties involved in handling wild
deer. Only insertion of the CIDRW progesterone device
and the EB applications were performed during physical
restraint [36] between 8:00 and 9:30 a.m. To perform
the other procedures, the hinds were led to a restraint
box. All the hinds received a second i.m. injection of
265 μg of cloprostenol 14 days after the removal of the
CIDR® device used to induce luteolysis of multiple cor-
pora lutea (CL).
Assessment of ovarian stimulation
The ovulation rate was evaluated by CL counts and total
follicular stimulation was evaluated by CL and counts of
large (over 3 mm [6]) unruptured follicles seven days after
the first copulation [22] (or day 9 or 10 following the com-
pletion of treatment for deer that showed no behavioral
estrus) by laparoscopy, such that hinds with two or more
CL were defined as having superovulated. The procedure
involved with holding food and water from the hinds for
24 h and physical restraint, followed by anesthesia, as pre-
viously described for M. gouazoubira [6]. The laparoscopic
procedures used were the same as those described for red
deer [12]. The incisions were closed with 2–0 nylon sutureD-8          D-7        D-6 D-5 D-4 
D-8          D-7        D-6 D-5 D-4 
Figure 1 Two superovulation treatments performed on six hinds of the
EB D-8 + 700UI eCG D-4 + cloprostenol D0) and FSH Treatment (CIDRÒ
D0).and the hinds were treated with benzathine penicillin
(Pentabiotic; Fort Dodge, Campinas, Brazil, 40,000 IU/
Kg i.m.) and monophenylbutazone (Monofenew; Vetnil,
Louveira, Brazil, 5 mg/Kg, i.v.).
Behavioral data and sample collection
Signs of estrous behavior were determined by allowing
each hind to associate with a vasectomized male adult
(10 min every 12 h) from 12 h after the completion of
the treatments until the moment that the hind no longer
accepted copulation (end of estrus). Behavioral estrus
was defined as the period in which hinds permitted
copulation [3]. Fecal samples were collected daily (be-
tween 7:30–9:30 h) from two days prior to the onset of
treatment (progesterone device insertion) until five days
after the completion of the treatment (progesterone de-
vice removal) and from the day of laparoscopy (day 7
after first copulation or day 9 or 10 after the completion
of treatment for deer that showed no behavioral estrus)
until the final (second) application of cloprostenol (day 14
following removal of the device). Fecal samples were also
collected on day 17 following removal of the device. Each
sample recovered within 12 h of voiding was placed in in-
dividually labeled plastic bags. The fecal samples were fro-
zen (−20°C) within 20 min of collection. All the samples
were stored at -20°C until steroid analysis was performed.
Fecal steroid extraction and enzyme immunoassays (EIA)
The fecal samples (total amount collected) for each treat-
ment were dried in an oven (Mod. 320-SE, Fanem Ltda.,
São Paulo, Brazil) at 56°C for approximately 72 h [37]. The
dried fecal samples were pulverized and the steroids were
extracted from the feces according to the method described
by Graham et al. [38]. A proportion of the resulting powderD-3 D-2 D-1         D-0      D1 D2 
D-3 D-2 D-1        D-0       D1 D2 
species Mazama gouazoubira: eCG Treatment (CIDRÒ for 8 days +
for 7.5 days + EB D-7.5 + 130 mg FSH D-3 / D0.5 + cloprostenol
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nol. After vortexing for 30 s at high speed, the sample was
shaken for 12 h on a mechanical shaker. Following centrifu-
gation at 375 g for 20 min, the supernatant was transferred
into a clean tube. Aliquots of supernatant were diluted,
1:250 for the progesterone assay and 1:8 for the cortisol
assay, for EIA analyses (Multiskan MS, Labsystem, Helsinki,
Finland). The concentrations were determined using CL425
and R4866 antibodies (C.J. Munro, University of California;
Davis, CA, USA) for progestogens and glucocorticoid, re-
spectively. These antibodies were chosen due to their high
cross-reactivity with the metabolites excreted in M. goua-
zoubira feces, 5α- and 5β-pregnanes and cortisol [39]. Valid-
ation of the hormone dosages was performed according to
Brown et al. [40], by observation of the parallel dispos-
ition between the standard curve and that formed by
the pool of fecal extracts prepared by serial dilution and
by substantial recovery of exogenous progesterone (y =
0.99× + 1.14, r2 = 0.98) and cortisol (y = 0.8664× + 21.20,
r2 = 0.99) added to fecal extracts. Interassay coefficients
of variation for two separate controls were 4% (30% bind-
ing) and 17% (70% binding) for fecal progestogens metabo-
lites and 9% (27% binding) and 14% (69% binding) for fecal
corticosteroids metabolites. Intraassay coefficients of vari-
ation were <10%. Physiological validation to assess the
physiological relevance of measuring fecal glucocorticoid
metabolites (FGM) in M. gouazoubira, has already been de-
termined by Christofoletti et al. [32]. All fecal data are
expressed on a dry-weight basis.
Statistical analysis
For analysis of data presented as mean ± standard error
of the mean (SEM), the Student t test for independent
samples was used. Nonparametric data (presence or ab-
sence of superovulation, presence or absence of behav-
ioral estrus and regression or not regression of CL) were
analyzed using the Fisher Exact test. To assess the sig-
nificance of the differences between means for number
of CL in the right or left ovary within each treatment,
the Student t test for dependent samples was used. The
fecal hormone concentration values were submitted to
analysis of variance following logarithmic transformation
of the hormone data [41]. For analyses of the mean
FGM, each treatment was divided into five different
phases: Pre, two days before treatment; Early, the first
four days of treatment; Late, the last four days of treat-
ment; Total, the entire treatment period; and Post, five
days after treatment. To examine the effects of these five
phases on FGM, within each treatment, repeated mea-
sures analysis of variance (ANOVA) was used, followed
by the Tukey multiple comparison test. To examine the
effects of treatment on FGM, the Student t test for inde-
pendent samples was used. The mean fecal progesterone
metabolites (FPM) produced by the CL (corpora lutea,luteal phase), was calculated from the mean FPM of each
of the hinds, between laparoscopy (day 7 after first copu-
lation or day 9 or 10 after the completion of treatment
for deer that showed no behavioral estrus) and the final
(second) application of cloprostenol (day 14 following
removal of the device); the mean and SEM were calcu-
lated based on the results of four values from eCG
Treatment and five values from FSH Treatment. Hinds 3
and 5 were excluded from the mean of anovulatory folli-
cles, total follicle stimulation, number of CL and luteal
FPM for eCG Treatment, while hind 3 has was excluded
from the same means for FSH Treatment due to the
repetition of estrous behavior before the laparoscopic
examination. To compare the mean FPM during the lu-
teal phase, on days 14 and 17 (following removal of the
device), between treatments, the Student t test for inde-
pendent samples was used to analyze the effects of the
treatments on FPM. To compare FPM on days 14 and
17 (following removal of the device), within each treat-
ment, the Student t test for dependent samples was used
to determine the effects of days on FPM. Hinds 2 and 5
were excluded from the FPM means on days 14 and 17
in both treatments due to the repetition of estrous be-
havior in the period between the laparoscopic procedure
and day 14 following removal of the CIDRW device. All
hormones analyzes were performed considering the delay
time (24 h) between hormonal events in the plasma and
the appearance of the respective signal in the feces. The
Pearson correlation test was used to correlate the FGM
from the Late Treatment phase with FPM produced by CL
and the number of anovulatory follicles. Correlations were
analyzed using combined data from both treatments. All
analyzes were performed using MinitabW 14 (Minitab Inc.,
State College, Pennsylvania State University, USA). Values
were considered significant when P < 0.05.
Results
Estrus and ovarian response
The results for estrus and superovulatory response are pre-
sented in Table 1. The number of hinds in estrus, supero-
vulated hinds, the interval between the completion of
treatment and the onset of estrus and duration of estrus
did not differ between the treatments (P ≥ 0.05). The
period between the completion of treatment and the onset
of estrus ranged from 24–48 h and for eCG Treatment
and 48–120 h for FSH Treatment. Thus, synchrony, i.e.
the interval between the first and last female showing the
estrous behavior, was better in eCG Treatment than in
FSH Treatment.
Regarding ovulatory response, eCG Treatment resulted
in the highest number of CL (P < 0.05). However, the
mean rate of anovulatory follicles and total ovarian stimu-
lation were not significantly different between treatments
(Table 1). In addition, no significant differences were
Table 1 Mean (±SEM) time to estrus and superovulatory response in six hinds of the species Mazama gouazoubira
submitted to two different hormonal treatments
Treatments P value
eCG FSH
Number of hinds treated per treatment 6 6
Hinds exhibiting estrus behavior 3/6 3/6 NS
Period between removal of the progesterone
device and the onset of estrus (h) (range)
40.0 ± 8.0 (24–48) 92.0 ± 22.0 (48–120) NS
Duration of estrus (h) (range) 40.0 ± 4.0 (36–48) 36.0 ± 6.9 (24–48) NS
Synchronya (h) 24 72
Superovulating hinds 4/6 4/6 NS
No. of corpora lutea (range) 7.0 ± 1.8a* (2–10) 2.6 ± 0.8b* (1–6) 0.04
No. of corpora lutea in the right ovary (range) 4.2 ± 1.2* (1–7) 1.0 ± 0.3* (0–2) NS
No. of corpora lutea in the left ovary (range) 2.7 ± 0.8* (0–5) 1.6 ± 0.8* (0–2) NS
No. of anovulatory follicles (range) 4.5 ± 1.7* (0–7) 7.6 ± 0.9* (6–11) NS
Total follicular stimulusb (range) 11.5 ± 2.5* (6–17) 10.2 ± 1.1* (7–13) NS
Hinds with early regression of corpora lutea 4/6 2/6 NS
eCG Treatment, CIDR® for 8 days + BE D0 + 700UI eCG D4 + cloprostenol D8; and FSH Treatment, CIDR® for 7.5 days + BE D0 + 130 mg FSH D4.5/D8 + cloprostenol D7.5.
aPeriod between the first and last hind to exhibit estrus behavior under each treatment.
bSum of the number of corpora lutea and the number of anovulatory follicles.
*Mean ± SEM, excluding data from hinds 3 and 5 in eCG Treatment and hind 3 in FSH Treatment due to repetition of estrus behavior prior to laparoscopic examination.
NS: P ≥ 0:05; Values with different letters (a and b) along the lines differ (P < 0:05) according to the Student t test.
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left ovaries within each treatment.
Hind 5 did not present estrous behavior immediately
following completion of the eCG Treatment, but on the
day of the laparoscopic examination (10 days after removal
of the CIDR® device), during which, the presence of two
CL, two CL in regression and two large ovulatory follicles
were observed. This treatment also revealed the presence
of corpora albicantia and CL with signs of regression in
hinds 2 and 4. These deer presented estrous behavior 12
and 14 days after the completion of eCG Treatment, re-
spectively. Estrous behavior was not observed in hind 4
immediately following the removal of the CIDRW device.
In eCG and FSH Treatments, hind 3 presented repetition
of behavioral estrus two days before the laparoscopic exam-
ination (7 days after the completion of treatment). During
the exam, the presence of CL, large follicles and small dif-
fuse follicles were all observed. CL showing signs of regres-
sion were also observed for hind 4 in FSH Treatment.
Hinds 2, 3, 4, 5 and 6 presented behavioral estrus (lasting
up to 3 days) following the administration of EB and con-
tinued to cycle in the period between treatments. With the
exception of hinds 2, 4 and 5 in eCG Treatment and hinds
2 and 5 in FSH Treatment, all the other deer showed be-
havioral estrus following the final administration of clopros-
tenol (14 days after the removal of the CIDRW device).
Endocrine profiles
The mean FGM during the five different phases of eCG
and FSH Treatments are shown in Figure 2. No significantdifferences in FGM concentration were determined be-
tween the treatments for the five different phases; however,
the Pre treatment FGM concentration was significantly dif-
ferent from the Late treatment in FSH Treatment.
Regarding the two SOV protocols, the mean FPM pro-
duced by the CL (luteal phase) was higher (P < 0.05) in
eCG Treatment than in FSH Treatment (Table 2). Admin-
istration of cloprostenol 14 days after removal of the
CIDRW device was associated with the demise of luteal tis-
sue, as indicated by the abrupt decline (P < 0.05) in mean
FPM in eCG Treatment 72 h later (Table 2). A fall in
mean FPM in FSH Treatment also occurred, though this
was not significant.
Correlations
The correlation analysis showed a positive correlation be-
tween FGM and number of anovulatory follicles (0.52, P ≥
0.05), and a negative correlation between FGM and FPM
(−0.12, P ≥ 0.05).
Discussion
Our analysis of the results of this study show that the two
proposed treatments (eCG Treatment, CIDRW for 8 days +
EB D0 + 700UI eCG D4 + cloprostenol D8; and FSH
Treatment, CIDRW for 7.5 days + EB D0 + 130 mg FSH
D4.5/D8 + cloprostenol D7.5) were capable of promoting a
superovulatory response; however, eCG Treatment pro-
duced the greatest number of corpora lutea, while FSH
Treatment promoted only a minimal response (2.6 ± 0.8































Figure 2 Mean (±SEM) fecal glucocorticoid metabolites (ng/g
feces) of six brown brocket deer (Mazama gouazoubira) hinds
for five different phases (Pre, two days before treatment; Early,
the first four days of treatment; Late, the last four days of
treatment; Total, entire treatment period; and Post, five days
after treatment) of two treatments: eCG, CIDRÒ for 8 days + BE
D0 + 700UI eCG D4 + cloprostenol D8, gray bars; and FSH, CIDRÒ
for 7.5 days + BE D0 + 130 mg FSH D4.5 / D8 + cloprostenol D7.5,
black bars. Means within FSH Treatment with different letters (a and
b) differ (P < 0.05) according to the Tukey test.
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(7.0 ± 1.8 CL) was similar to the means obtained in the
species D. dama (6 to 10 CL [11,13,18]) and C. elaphus,
which have already been selected for MOET programs
(mean of 5 to 12 CL [10–13,15-17 ]). Moreover, this mean
was higher than the ovulation means obtained for other
species, such as E. davidianus (CL 3.83 [15]), O. virginia-
nus (3.10 CL [19]) and C. elaphus, which were not selected
for a MOET program (2.15 CL [14]). Higher mean ovula-
tion (3.40 ± 0.68 CL) has already been obtained for the
species M. gouazoubira, in a previous experiment which
used similar SOV protocols with modifications in the EB
dosage (0.5 mg) used to induce ovulatory follicular atresia
and synchronize the follicle wave in conjunction with the
CIDRW and eCG (600UI) used to induce SOV [7].
These two modifications in the protocol could begin to
explain the differences between the ovulatory rates ob-
tained in eCG Treatment and in the previous study withTable 2 Mean (±SEM) fecal progesterone metabolites [FPM] o
different phases of two hormonal treatments
[FPM] luteala (ng/g feces) 4293.6
[FPM] pre-PGFb (ng/g feces) 4002.76
[FPM] post-PGFc (ng/g feces) 1147.18
1, CIDR® for 8 days + EB D0 + 700UI eCG D4 + cloprostenol D8; and 2, CIDR® for 7.5 d
a[FPM] in the period between laparoscopy and day 14 following removal of the CID
the final PGF2α injection;
c[FPM] on day 17 following removal of the CIDR® device /3
and 5 in eCG Treatment and hind 3 in FSH Treatment due to repetition of estrus be
**Mean ± SEM, excluding data from hinds 2 and 5 in eCG and FSH Treatments due
examination and day 14 following removal of the CIDR® device. NS: P ≥ 0.05; Means
according to the paired Student t test; Means within each row with different lowercthe same species. The use of a lower dose of EB and a
higher dose of eCG seem to have been a positive factor. It
has already been shown that high levels of estradiol at the
moment of insertion of the progesterone implant and
early administration of gonadotropins have a negative im-
pact on superovulatory response and on follicular wave
synchronization [23,42] and that the ovulation rate in-
creases in a dose-dependent manner [43] in relation to an
increase in the eCG dosage [7]. However, even using a
lower dose of EB, it is probable the protocol is not yet well
adjusted to the needs of this species, since the hinds pre-
sented behavioral estrus following the administration of EB.
Another factor that could explain the lower ovulation rate
obtained in the previous study are changes in luteinizing
hormone (LH) pulsatility caused by stress induced by man-
ual physical restraint [44] during the hormone applications,
which in this present study were substituted by leading the
deer to a restraint box.
Although considered low, the ovulation rate obtained in
FSH Treatment was three times higher than the rate ob-
tained in a previous study (0.80 ± 12:49 CL) involving the
species M. gouazoubira, which used 250 IU FSH (PlusetW,
CalierW, Spain) administered in a single application, to-
gether with a synthetic organic polymer (polyvinylpyrroli-
done), used in the processing of long-acting drugs [7]. The
regime of multiple FSH applications seems to be the most
suitable for stimulating SOV in cervids; however, despite
the way it was conducted, it still seems inadequate to pro-
vide good ovulatory stimulus, since the total follicular
stimulation of eCG and FSH Treatments were similar, but
the ovulation rate of eCG Treatment was approximately
2.5 times greater than that for FSH Treatment.
In general, the system of multiple FSH applications is in-
fluenced by the effects of stress management [24,25], as
suggested by the significant increase in FGM concentra-
tions after day 4 of FSH Treatment, when the FSH appli-
cations were initiated. The FGM levels increased during
period of intensive management of the deer, as previously
reported for Gazella dama mhorr [24]. Although the
FGM levels of FSH Treatment were higher, no significantf hinds of the species Mazama gouazoubira, in the
Treatments
eCG FSH
9 ± 769.47a* 1571.26 ± 240.28b*
± 11019.48Aa** 1296.09 ± 175.69Aa**
± 267.40Ba** 424.82 ± 104.37Aa**
ays + BE D0 + 130 mg FSH D4.5/D8 + cloprostenol D7.5.
R® device; b[FPM] on day 14 following removal of the CIDR® device/the day of
days after the final PGF2α injection; *Mean ± SEM, excluding data from hinds 3
havior prior to laparoscopic examination.
to repetition of estrus behavior in the period between laparoscopic
within each column with different capital letters (A and B) differ (P < 0.05)
ase letters (a and b) differ (P < 0.05) according to the Student t test.
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indicate that only one application of eCG on day 4 was suf-
ficient to increase FGM concentrations and that the use of
eCG provided extra gonadotrophic stimulation for ovula-
tion [45] in eCG Treatment, as reported in studies with
other deer species that combine low doses of eCG at the
end of treatments with FSH [45] due to the lack of SOV re-
sponse when FSH was used alone [14]. The reinforcement
of eCG on the preovulatory peak in eCG Treatment can
also be inferred from shorter synchrony period of this
treatment, suggesting that stimulation of ovulation of a
greater number of follicles occurred in a shorter period of
time [45].
The use of eCG has been associated with the occurrence
of asynchronous follicular development and anovulatory
follicles in numbers proportional to the doses used [43].
However, the occurrence of anovulatory follicles in this
study does not seem to be exclusively related to the use of
eCG, since FSH treatment also resulted in numerous an-
ovulatory follicles. The high levels of FGM during the fol-
licular growth phase should also be considered as an
important factor in the occurrence of these follicles, due
to endocrine disorders caused by the release of corticoste-
roids [46] and/or progesterone production by the adrenal
gland [47], which can inhibit the LH peak and/or affect
oocyte competence [24], resulting in lower receptor acqui-
sition and, consequently, lower responsiveness to LH [48].
Other factors, including the high concentrations of estra-
diol secreted by anovulatory follicles, can also significantly
reduce the rates of ovulation and total ovarian stimulation,
as well as promoting premature regression of approxi-
mately 10% of the CL, similar to that previously reported
for C. elaphus [8,16,49] and other domestic species [21,50].
Although both treatments resulted in a large number of
anovulatory follicles, in eCG Treatment, four hinds (66.7%)
presented repetition of behavioral estrus and signs of pre-
mature regression of CL, whereas in FSH Treatment, only
two hinds (33.3%) showed the same signs, suggesting that
premature regression is more closely associated with the
use of eCG and its prolonged action than the mere occur-
rence of anovulatory follicles.
In addition to these factors, it is important to consider
that the ovulation rates obtained in this study may have
been influenced by the administration of gonadotropins at
an inappropriate time in the follicular wave, since the first
study that induced follicular wave emergence in cervids
was developed in C. elaphus, during anestrus, and demon-
strated the onset of a new wave 5.2 ± 0.2 days following
the administration of progesterone and estradiol-17β [34].
Moreover, the use of an ovulation inductor could have im-
proved the ovulation rates and should be considered in fu-
ture protocols.
The profiles of FPM concentration during the luteal
phase associated with the surgical view of corpora lutearevealed a luteal source of secretion following by ovulation
in both treatments. The increase in the ovulation rate was
associated with increased progesterone secretion as a re-
sult of the significant increase in luteal tissue mass [7,13].
The secretion of progesterone during this period was ap-
parently not influenced by the secretion of glucocorticoids
in the final phase of the treatments, as confirmed by the
correlation value obtained and as previously reported by
González et al. [24]. However, this result could have been
influenced by the production of progesterone in the ad-
renal gland [47] and/or individual variations among the
small sample of deer used in the study.
As previously reported for the species M. gouazoubira
[7], administration of cloprostenol 14 days after the com-
pletion of treatment resulted in rapid destruction of luteal
tissue and a return to baseline concentrations of proges-
terone within 72 hours. This fact is relevant in embryo
transfer programs to prevent the implantation of embryos
that may remain following collection and to resynchronize
the females for natural mating [13].
Conclusions
In conclusion, our results indicate that although the eCG
Treatment (700UI eCG) induced a good superovulatory re-
sponse, with the formation of functional corpora lutea, we
cannot yet affirm that we have established a suitable proto-
col for induction of SOV in the speciesM. gouazoubira be-
cause approximately 65% of the deer showed premature
regression of the corpora lutea. Moreover, multiple FSH
applications in FSH Treatment resulted in a low ovulation
rate and induced an increase in FGM levels.
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